Brief: 60 Degrees Pharma Provides University Of Kentucky With Right Of Reference To Arakoda® NDA In Support Of Sj733 Phase 2b Study

60 Degrees Pharmaceuticals

12/08/2024 14:29

Aug 12 (Reuters) - 60 Degrees Pharmaceuticals Inc
 SXTP.O :
    * 60 DEGREES PHARMA PROVIDES UNIVERSITY OF KENTUCKY WITH
RIGHT OF
REFERENCE TO ARAKODA® NDA IN SUPPORT OF SJ733 PHASE IIB STUDY
    * UNIVERSITY WILL COMMENCE PHASE IIB CLINICAL STUDY OF DRUG
DEVELOPMENT CANDIDATE SJ733 FOR TREATMENT OF VIVAX MALARIA
    * 60 DEGREES PHARMA WILL SUPPLY TAFENOQUINE AND PLACEBOS AS
STUDY
DRUGS IN UNIVERSITY OF KENTUCKY PHASE IIB TRIAL
    * RIGHT OF REFERENCE ALLOWS FDA TO REVIEW CO'S REGULATORY
FILE
WHEN IT EVALUATES SJ733-TAFENOQUINE PHASE IIB STUDY PROTOCOLS
    * EISAI WILL MANAGE MANUFACTURE OF A NEW BATCH OF SJ733
CLINICAL
TRIAL MATERIAL

Source text for Eikon:  ID:nGNX4qZ84J 
Further company coverage:  SXTP.O 

 ((Reuters.Briefs@thomsonreuters.com;))